The SEC has a new boss for its Corporation Finance Division. James Moloney, a well-known figure in corporate securities law, is stepping into this important role. He's no stranger to the SEC, having worked there before from 1994 to 2000. After that, he spent time at a big law firm, Gibson Dunn & Cru
Michael Fiddelke is set to take the reins at Target, stepping into the CEO role in February. This move comes after a long journey within the company, starting as a humble intern over two decades ago. Before joining Target, Fiddelke spent time at Deloitte and earned his MBA from Northwestern Universi
President Trump recently picked EJ Antoni to lead the Bureau of Labor Statistics (BLS). This choice has sparked a lot of debate. Some people, like Steve Bannon, think Antoni is a great fit. Others, like Jason Furman, believe he lacks the right experience. The main concern is whether Antoni can keep
Mexico's President Claudia Sheinbaum has chosen Maria del Carmen Bonilla to be the new deputy finance minister. This decision ends weeks of guessing about who would take the job. Bonilla has been working at the finance ministry since 2021. She has been in charge of the unit that deals with public c
Susan Monarez is now the official head of the Centers for Disease Control and Prevention (CDC). The Senate voted to confirm her, with 51 votes in favor and 47 against, strictly along party lines. This comes after she was nominated by President Trump in March. He described her as a "dedicated public
Shailesh Jejurikar, a 58-year-old executive, is set to take the helm at Procter & Gamble (P&G) on January 1st. He will succeed Jon Moeller, who has been at the company's head since 2021 and will now take on the role of executive chairman. Jejurikar, who has been with P&G since 1989, has a strong tra
Mayor Brandon Johnson is once again at a crossroads, needing to pick a new leader for the Zoning Committee. This time, the decision is even more crucial as it's his third attempt. The current leader, Ald. Walter Burnett, is stepping down, leaving a big void. This isn't just any committee; it's one o
Mario Cazzola has taken on a new role as an honorary editor for the journal Pulmonary Pharmacology & Therapeutics. This is a big deal because it means he gets to help shape the future of research in this field. But what does this really mean for the world of respiratory medicine? First, let's talk
Doctors have a lot on their plates. They see many patients in a day, and each visit is packed with important health discussions. But there's a common phrase that can throw a wrench into their schedules: "Just one more thing. " This simple phrase often pops up at the end of an appointment, when the d
Jared Isaacman had a plan. He was close to becoming NASA's administrator. He had gone through months of checks, interviews, and a committee hearing. He was all set for a vote in the US Senate. Then, a phone call changed everything. The president's office wanted a different person for the job. This w
